Examination of potential mechanisms to explain the association between proton pump inhibitors and Clostridium difficile infection

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 10, 2009, Pages 4133-4137

  Nerandzic, Michelle M ^a   Pultz, Michael J ^a   Donskey, Curtis J ^a  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMINO ACID; PANTOPRAZOLE; PROTON PUMP INHIBITOR; TAUROCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL SPORE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM CULTURE; CECUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE ASSOCIATION; FEMALE; GERMINATION; HEAT SHOCK; HUMAN; INCUBATION TIME; MOUSE; NONHUMAN; PATHOGENESIS; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SMALL INTESTINE; STOMACH CONTENT; STOMACH PH; SURVIVAL RATE; TEMPERATURE;

ANIMALS; ANTI-BACTERIAL AGENTS; CECUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINES; MICE; PROTON PUMP INHIBITORS; SPORES, BACTERIAL; STOMACH;

EID: 70349328455     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00252-09     Document Type: Article

References (27)

1. Al-Tureihi, F. I. J., et al. 2005. Albumin, length of stay, and proton pump inhibitors: key factors in Clostridium difficile-associated disease in nursing home patients. J. Am. Med. Dir. Assoc. 6:105.
2. Collins, B. J., G. Crothers, R. J. McFarland, and A. H. G. Love. 1985. Bile acid concentrations in the gastric juice of patients with erosive esophagitis. Gut 26:495-496.
3. Cunningham, R., B. Dale, B. Undy, and N. Gaunt. 2003. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J. Hosp. Infect. 54:243.
4. Dalton, B. R., T. Lye-Maccannell, E. A. Henderson, D. R. Macccannell, and T. J. Louie. 2009. Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting. Aliment. Pharmacol. Ther. 29:626-634.
5. Dial, S., J. A. C. Delaney, A. N. Barkun, and S. Suissa. 2005. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 294:2989-2995.
6. Dial, S., J. A. Delaney, V. Schneider, and S. Suissa. 2006. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ 175:745-748.
7. Duncan, C. L., and D. H. Strong. 1968. Improved medium for sporulation of Clostridium perfringens. Appl. Microbiol. 16:82-89.
8. Fiorucci, S., E. Distrutti, F. DiMatteo, P. Brunori, L. Santocci, F. Mallozzi, U. Bigazzi, and A. Morelli. 1995. Circadian variations in gastric acid and pepsin secretion and intragastric bile acid in patients with reflux esophagitis and in healthy controls. Am. J. Gastroenterol. 90:270-276.
9. Hitzman, D. O., H. O. Halvorson, and T. Ukita. 1957. Requirements for production and germination of spores of anaerobic bacteria. J. Bacteriol. 74:1-7.
10. Jump, R. L. P., M. J. Pultz, and C. J. Donskey. 2007. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with elevated pH. Antimicrob. Agents Chemother. 51:2883-2887.
11. Karasawa, T., S. Ikoma, K. Yamakawa, and S. Nakamura. 1995. A defined growth medium for Clostridium difficile. Microbiology 141:371-375.
12. Kaunitz, J. D., and G. Sachs. 1986. Identification of a vanadate-sensitive potassium-dependent proton pump from rabbit colon. J. Biol. Chem. 261: 14005-14010.
13. Loo, V. G., C. A. Fallone, E. DeSouza, J. Lavallee, and A. N. Barkun. 1997. In vitro susceptibility of Helicobacter pylori to ampicillin, clarithromycin, metronidazole and omeprazole. J. Antimicrob. Chemother. 40:881-883.
14. Loo, V. G., L. Poirier, M. A. Miller, M. Oughton, M. D. Libman, S. Michaud, A. Bourgault, T. Nguyen, C. Frenette, M. Kelly, A. Vibien, P. Brassard, S. Fenn, K. Dewar, T. J. Hudson, R. Horn, P. Rene, Y. Monczak, and A. Dascal. 2005. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 353:2442-2449.
15. McDonald, L. C., G. E. Killgore, A. Thompson, R. C. Owens, S. V. Kazakova, S. P. Sambol, S. Johnson, and D. N. Gerding. 2005. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 353:2433-2441.
16. Nerandzic, M. M., and C. J. Donskey. 2009. Effective and reduced-cost modified selective medium for isolation of Clostridium difficile. J. Clin. Microbiol. 47:397-400.
17. Reference deleted.
18. Pepin, J., N. Saheb, M. A. Coulombe, M. E. Alary, M. P. Corriveau, S. Authier, M. Leblanc, G. Rivard, M. Bettez, V. Primeau, M. Nguyen, C. E. Jacob, and L. Lanthier. 2005. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin. Infect. Dis. 41:1254-1260.
19. Poutanen, S. M., and A. E. Simor. 2004. Clostridium difficile-associated diarrhea in adults. CMAJ 171:51-58.
20. Rao, A., R. L. Jump, N. J. Pultz, M. J. Pultz, and C. J. Donskey. 2006. In vitro killing of nosocomial pathogens by acid and acidified nitrite. Antimicrob. Agents Chemother. 50:3901-3904.
21. Shah, S., A. Lewis, D. Leopold, F. Dunstan, and K. Woodhouse. 2000. Gastric acid suppression does not promote clostridial diarrhoea in the elderly. Q. J. Med. 93:175-181.
22. Sorg, J. A., and A. L. Sonenshein. 2008. Bile salts and glycine as cogerminants for Clostridium difficile spores. J. Bacteriol. 190:2505-2512.
23. Stiefel, U., R. L. Jump, and C. J. Donskey. 2006. Suppression of gastric acid production by proton pump inhibitor treatment facilitates colonization of the large intestine by vancomycin-resistant Enterococcus and Klebsiella pneumoniae in mice. Antimicrob. Agents Chemother. 50:3905-3907.
24. Reference deleted.
25. Wilcox, M. H., L. Mooney, R. Bendall, C. D. Settle, and W. N. Fawley. 2008. A case-control study of community-associated Clostridium difficile infection. J. Antimicrob. Chemother. 62:388-396.
26. Wilson, K. H., J. N. Sheagren, and R. Freter. 1985. Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster. J. Infect. Dis. 151:355-361.
27. Yearsley, K. A., L. J. Gilby, A. V. Ramadas, E. M. Kubiak, D. L. Fone, and M. C. Allison. 2006. Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea. Aliment. Pharmacol. Ther. 24:613-619.